Cohen, T., Lipsitch, M., Walensky, R. P., & Murray, M. (2006). Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations. National Academy of Sciences.
Citación estilo ChicagoCohen, Ted, Marc Lipsitch, Rochelle P. Walensky, and Megan Murray. Beneficial and Perverse Effects of Isoniazid Preventive Therapy for Latent Tuberculosis Infection in HIV–tuberculosis Coinfected Populations. National Academy of Sciences, 2006.
Cita MLACohen, Ted, Marc Lipsitch, Rochelle P. Walensky, and Megan Murray. Beneficial and Perverse Effects of Isoniazid Preventive Therapy for Latent Tuberculosis Infection in HIV–tuberculosis Coinfected Populations. National Academy of Sciences, 2006.